Procter & Gamble Company (The) $PG Shares Bought by Forvis Mazars Wealth Advisors LLC

Forvis Mazars Wealth Advisors LLC boosted its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 3.3% during the 2nd quarter, Holdings Channel.com reports. The firm owned 46,258 shares of the company’s stock after purchasing an additional 1,480 shares during the quarter. Forvis Mazars Wealth Advisors LLC’s holdings in Procter & Gamble were worth $7,370,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC acquired a new stake in Procter & Gamble during the 1st quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD grew its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. grew its position in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC increased its stake in shares of Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares in the company, valued at $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Balaji Purushothaman sold 490 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday, October 10th. Bank of America cut their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas Exane cut their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Finally, Wells Fargo & Company cut their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $172.21.

Procter & Gamble Price Performance

NYSE:PG opened at $151.53 on Friday. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43. The stock has a 50 day moving average of $154.92 and a two-hundred day moving average of $158.77. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market cap of $354.66 billion, a P/E ratio of 23.28, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period in the previous year, the business earned $1.40 EPS. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a $1.0568 dividend. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is 64.98%.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.